The latest data from GuruFocus shows that PRESIDENT, CEO & CHAIRMAN, 10% Owner N/A bought 100000 shares of Fortress Biotech Inc (FBIO) on 2022-10-21.
When insiders buy shares of their company’s stock, it can often be a positive sign. It could signal that insiders are turning bullish on the future of their company. Insiders know far more about their company than the general public does, so it is worth paying attention to their trades. With this in mind, let’s take a look at this insider buy to see if Fortress Biotech Inc deserves the attention of investors.
ROSENWALD LINDSAY A MD’s trades
Over the past year, ROSENWALD LINDSAY A MD has purchased 0 shares in total.
This means that ROSENWALD LINDSAY A MD has been buying their company’s stock over the long term. This could be a positive sign for the stock’s future.
Insider trends
Some investors may wonder whether one insider’s buys are that important. Are other insiders buying the stock as well, or are other insiders selling?
The insider transaction history for Fortress Biotech Inc shows than there have been 1 insiders buys in total over the past year. Meanwhile, there have been 1 insider sells over the same timeframe.
Although ROSENWALD LINDSAY A MD has been buying shares recently, it seems that most of their peers are selling. However, insiders sell for many reasons. Maybe they need the cash, or maybe they are trying to lower their taxes. High insider selling could be a bad sign or a neutral sign, depending on the reason for the sales.
Valuation
Shares of Fortress Biotech Inc were trading for $0.7898 apice on the day of ROSENWALD LINDSAY A MD’s recent buy. This gives the stock a market cap of $78.905 Millions.
With a price of $0.7898 and a GuruFocus Value $3.74, Fortress Biotech Inc has a price-to-GF-Value ratio of 0.21. This means the stock is {SIGNIFICANTLY OVERVALUED / MODESTLY OVERVALUED / FAIRLY VALUED / MODESTLY UNDERVALUED / SIGNIFICANTLY UNDERVALUED / A POSSIBLE VALUE TRAP} based on its GF Value.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
